BofA raised the firm’s price target on Concentra (CON) to $25 from $24 and keeps a Buy rating on the shares after the company announced an ...
Concentra reports a robust quarter with significant EBITDA growth and a promising outlook following the Nova Medical Centers acquisition.
ADDISON, Texas--(BUSINESS WIRE)--Concentra®, the nation’s leader in occupational medicine, today announced the opening of a new medical center in Northlake, Texas. The medical center ...